Clinical Trial Update: Safety of FMT: OpenBiome Outcomes and Longitudinal Follow-up (STOOL) for Recurrent Clostridium Difficile Infection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on safety of fecal microbiota transplantation (FMT) for recurrent Clostridium difficile infection with OpenBiome data and longitud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Difficile Infection

Drugs mentioned

• FMT (fecal microbiota transplantation)

Snippet

Sponsor: Microbiome Health Research Institute | Conditions: Clostridium Difficile | Phase 2 | Status: TERMINATED | Results posted: 2021-02-23